Lookup NU author(s): Professor Tiago Outeiro
Full text for this publication is not currently held within this repository. Alternative links are provided below where available.
© 2019 The Author(s). Published by Portland Press Limited on behalf of the Biochemical Society.Medical research has identified over 500 brain disorders. Among these, there are still only very few neuropathologies whose causes are fully understood and, consequently, very few drugs whose mechanism of action is known. No FDA drug has been identified for major neurodegenerative diseases, such as Alzheimer's and Parkinson's. We still lack effective treatments and strategies for modulating progression or even early neurodegenerative disease onset diagnostic tools. A great support toward the highly needed identification of neuroactive drugs comes from computer simulation methods and, in particular, from molecular dynamics (MD). This provides insight into structure-function relationship of a target and predicts structure, dynamics and energetics of ligand/target complexes under biologically relevant conditions like temperature and physiological saline concentration. Here, we present examples of the predictive power of MD for neuroactive ligands/target complexes. This brief survey from our own research shows the usefulness of partnerships between academia and industry, and from joint efforts between experimental and theoretical groups.
Author(s): Rossetti G, Kless A, Lai L, Outeiro TF, Carloni P
Publication type: Review
Publication status: Published
Journal: Biochemical Society transactions
Online publication date: 13/05/2019
Acceptance date: 23/04/2019
ISSN (print): 0300-5127
ISSN (electronic): 1470-8752
Publisher: NLM (Medline)
PubMed id: 31085614